State of Michigan Retirement System raised its position in Agilent Technologies Inc (NYSE:A) by 11.2% in the 2nd quarter, Holdings Channel reports. The firm owned 78,906 shares of the medical research company’s stock after buying an additional 7,937 shares during the period. State of Michigan Retirement System’s holdings in Agilent Technologies were worth $6,973,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Cubist Systematic Strategies LLC raised its position in shares of Agilent Technologies by 350.0% during the fourth quarter. Cubist Systematic Strategies LLC now owns 2,700 shares of the medical research company’s stock worth $230,000 after purchasing an additional 2,100 shares during the period. Sunbelt Securities Inc. bought a new position in Agilent Technologies in the fourth quarter valued at approximately $8,530,000. Macquarie Group Ltd. increased its position in shares of Agilent Technologies by 177.4% during the fourth quarter. Macquarie Group Ltd. now owns 281,444 shares of the medical research company’s stock worth $24,009,000 after acquiring an additional 179,994 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main acquired a new stake in shares of Agilent Technologies during the fourth quarter worth $89,000. Finally, Fulton Bank N.A. lifted its position in Agilent Technologies by 12.3% in the 1st quarter. Fulton Bank N.A. now owns 5,215 shares of the medical research company’s stock valued at $374,000 after acquiring an additional 573 shares in the last quarter.
In other Agilent Technologies news, VP Rodney Gonsalves sold 4,566 shares of the stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $85.30, for a total transaction of $389,479.80. Following the transaction, the vice president now owns 102,806 shares in the company, valued at approximately $8,769,351.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Heidi Fields sold 10,392 shares of Agilent Technologies stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $91.00, for a total value of $945,672.00. Following the sale, the director now directly owns 53,509 shares of the company’s stock, valued at approximately $4,869,319. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 42,009 shares of company stock valued at $3,558,488.
Agilent Technologies stock opened at $96.33 on Friday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.24 and a current ratio of 1.63. The stock has a 50-day simple moving average of $90.28 and a 200 day simple moving average of $82.78. The stock has a market capitalization of $29.74 billion, a P/E ratio of 44.39, a PEG ratio of 3.09 and a beta of 1.12. Agilent Technologies Inc has a 52 week low of $61.13 and a 52 week high of $98.09.
Agilent Technologies (NYSE:A) last posted its earnings results on Thursday, May 21st. The medical research company reported $0.71 earnings per share for the quarter, topping analysts’ consensus estimates of $0.61 by $0.10. Agilent Technologies had a return on equity of 20.76% and a net margin of 13.04%. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.20 billion. During the same period in the previous year, the firm earned $0.71 EPS. The firm’s revenue was up .2% compared to the same quarter last year. Research analysts forecast that Agilent Technologies Inc will post 3.12 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.75%. The ex-dividend date was Monday, June 29th. Agilent Technologies’s payout ratio is presently 23.15%.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
See Also: Cash Asset Ratio
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.